BIO-PATH HOLDINGS, INC. cotiza a 0.00 USD y tiene una capitalización bursátil de $15089. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. Its drug delivery and antisense technology is the DNAbilize, a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification that is intended…
| Periodo | 2025-11 | 2025-08 | 2025-05 | 2025-03 |
|---|---|---|---|---|
| Real | — | $-0.55 | $-0.40 | $-0.07 |
| Estimado | $-0.40 | $-0.40 | $-0.38 | $-0.37 |
| Sorpresa | — | -37.5% | -5.3% | +81.1% |
| Métrica | BPTH | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | — | -32.0% | — |
| Current Ratio | 0.08 | 2.84 | -2.76 |
| Debt / Equity | — | 0.28 | — |